Arkéa et al. back Nature et Stratégie
A group of French GPs has backed France-based Nature et Stratégie, a biological cosmetics and personal care products developer and retailer.
Arkéa Capital joined previous investors Ouest Croissance and Unexo, which both reinvested in Nature et Stratégie.
The GPs will help the business grow both organically and via acquisitions, according to a statement. It intends to expand in North America and in the UK.
Ouest Croissance first invested in the business in 2011, while Unexo joined a year later, according to press reports at the time. Both GPs provide tickets of up to €10m.
Company
Founded in 1985 and based in Somloire, the company produces and sells beauty and personal care products labelled as biological (without chemical treatment).The business has developed its products via an R&D laboratory established in 1995.
Nature et Stratégie employs 170 people and generates sales of €33m. The company has had activities in Asia since 2007 and currently also operates in Belgium and Switzerland.
People
Nature et Stratégie – Samuel Gabory (CEO).
Arkéa Capital – Thomas Trideau (regional director).
Ouest Croissance – Anne Jacquinet-Sulger (president).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









